N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated γ-secretase

被引:20
作者
Narlawar, Rajeshwar
Revuelta, Blanca I. Perez
Baumann, Karlheinz
Schubenel, Robert
Haass, Christian
Steiner, Harald
Schmidt, Boris
机构
[1] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, D-64287 Darmstadt, Germany
[2] Univ Munich, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany
[3] F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Preclin Res CNS, CH-4070 Basel, Switzerland
关键词
secretase; Alzheimer dementia; modulator; aspartic protease;
D O I
10.1016/j.bmcl.2006.09.061
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
N-Sulfonylated and N-alkylated carbazolyloxyacetic acids were investigated for the inhibition and modulation of the Alzheimer's disease associated gamma-secretase. The introduction of a lipophilic substituent, which may vary from arylsulfone to alkyl, turned 2-carbazolyloxyacetic acids into potent gamma-secretase modulators. This resulted in the selective reduction of A beta(42) and an increase of the less aggregatory A beta(38) fragment by several compounds (e.g., 7d and 8c). Introduction of an electron donating group at position 6 and 8 of N-substituted carbazolyloxyacetic acids either decreased the activity or inversed modulation. The most active compounds displayed activity on amyloid precursor protein (APP) overexpressing cell lines in the low micromolar range and little or no effect on the gamma-secretase cleavage at the F-site. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 33 条
[1]
HLA-DR4 influences glial activity in Alzheimer's disease hippocampus [J].
Aisen, PS ;
Luddy, A ;
Durner, M ;
Reinhard, JF ;
Pasinetti, GM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 161 (01) :66-69
[2]
5-(3-CARBOXYMETHOXYPHENYL)-2-(4,5-DIMETHYLTHIAZOLYL)-3-(4-SULFOPHENYL)TETRAZOLIUM, INNER SALT (MTS) AND RELATED ANALOGS OF 3-(4,5-DIMETHYLTHIAZOLYL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE (MTT) REDUCING TO PURPLE WATER-SOLUBLE FORMAZANS AS CELL-VIABILITY INDICATORS [J].
BARLTROP, JA ;
OWEN, TC ;
CORY, AH ;
CORY, JG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (11) :611-&
[3]
Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor [J].
Barten, DM ;
Guss, VL ;
Corsa, JA ;
Loo, A ;
Hansel, SB ;
Zheng, M ;
Munoz, B ;
Srinivasan, K ;
Wang, B ;
Robertson, BJ ;
Polson, CT ;
Wang, J ;
Roberts, SB ;
Hendrick, JP ;
Anderson, JJ ;
Loy, JK ;
Denton, R ;
Verdoorn, TA ;
Smith, DW ;
Felsenstein, KM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (02) :635-643
[4]
BEHER D, 2005, Patent No. 2005013985
[5]
BOEHM HJ, 2000, VIRTUAL SCREENING BI
[6]
DELAYED-ONSET OF ALZHEIMERS-DISEASE WITH NONSTEROIDAL ANTIINFLAMMATORY AND HISTAMINE-H2 BLOCKING-DRUGS [J].
BREITNER, JCS ;
WELSH, KA ;
HELMS, MJ ;
GASKELL, PC ;
GAU, BA ;
ROSES, AD ;
PERICAKVANCE, MA ;
SAUNDERS, AM .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :523-530
[7]
Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling [J].
Brockhaus, M ;
Grünberg, J ;
Röhrig, S ;
Loetscher, H ;
Wittenburg, N ;
Baumeister, R ;
Jacobsen, H ;
Haass, C .
NEUROREPORT, 1998, 9 (07) :1481-1486
[8]
Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila [J].
Chung, HM ;
Struhl, G .
NATURE CELL BIOLOGY, 2001, 3 (12) :1129-1132
[9]
γ-secretase as a therapeutic target for the treatment of Alzheimer's disease [J].
Churcher, I ;
Beher, D .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (26) :3363-3382
[10]
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain [J].
De Strooper, B ;
Annaert, W ;
Cupers, P ;
Saftig, P ;
Craessaerts, K ;
Mumm, JS ;
Schroeter, EH ;
Schrijvers, V ;
Wolfe, MS ;
Ray, WJ ;
Goate, A ;
Kopan, R .
NATURE, 1999, 398 (6727) :518-522